DK1276732T3 - R-2-aminoaryl-propionsyreamider til anvendelse ved forebyggelse af leukocytaktivering - Google Patents
R-2-aminoaryl-propionsyreamider til anvendelse ved forebyggelse af leukocytaktiveringInfo
- Publication number
- DK1276732T3 DK1276732T3 DK01919448T DK01919448T DK1276732T3 DK 1276732 T3 DK1276732 T3 DK 1276732T3 DK 01919448 T DK01919448 T DK 01919448T DK 01919448 T DK01919448 T DK 01919448T DK 1276732 T3 DK1276732 T3 DK 1276732T3
- Authority
- DK
- Denmark
- Prior art keywords
- aminoaryl
- amides
- propionic acid
- acid amides
- leukocyte activation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/20—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/20—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Dermatology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2000MI000836A IT1318466B1 (it) | 2000-04-14 | 2000-04-14 | Ammidi di acidi r-2-(amminoaril)-propionici, utili nella prevenzionedell'attivazione leucocitaria. |
PCT/EP2001/004137 WO2001079189A2 (en) | 2000-04-14 | 2001-04-11 | 'amides of r-2-(aminoaryl)-propionic acids for use in theprevention of leucocyte activation' |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1276732T3 true DK1276732T3 (da) | 2008-02-25 |
Family
ID=11444862
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01919448T DK1276732T3 (da) | 2000-04-14 | 2001-04-11 | R-2-aminoaryl-propionsyreamider til anvendelse ved forebyggelse af leukocytaktivering |
Country Status (16)
Country | Link |
---|---|
US (1) | US7217707B2 (da) |
EP (1) | EP1276732B1 (da) |
AT (1) | ATE374193T1 (da) |
AU (2) | AU2001246539B2 (da) |
CA (1) | CA2420585C (da) |
CY (1) | CY1107078T1 (da) |
CZ (1) | CZ303407B6 (da) |
DE (1) | DE60130644T2 (da) |
DK (1) | DK1276732T3 (da) |
ES (1) | ES2292574T3 (da) |
HK (1) | HK1051035A1 (da) |
IT (1) | IT1318466B1 (da) |
NO (1) | NO325650B1 (da) |
PT (1) | PT1276732E (da) |
RU (1) | RU2268263C2 (da) |
WO (1) | WO2001079189A2 (da) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMI20010395A1 (it) * | 2001-02-27 | 2002-08-27 | Dompe Spa | Omega-amminoalchilammidi di acidi r-2-aril-propionici come inibitori della chemiotassi di cellule polimorfonucleate e mononucleate |
JP3801559B2 (ja) | 2002-12-26 | 2006-07-26 | ソニー株式会社 | 通信装置および方法、記録媒体、並びにプログラム |
EP1457485A1 (en) | 2003-03-14 | 2004-09-15 | Dompé S.P.A. | Sulfonic acids, their derivatives and pharmaceutical compositions containing them |
ATE347883T1 (de) * | 2004-03-25 | 2007-01-15 | Dompe Pha R Ma Spa Res & Mfg | Verwendung von n-(2-aryl-propionyl)-sulfonamiden zur behandlung von rückenmarkverletzungen |
EP1739078A1 (de) | 2005-05-30 | 2007-01-03 | Jerini AG | C5a-Rezeptor-Antagonisten |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH526538A (de) * | 1967-07-22 | 1972-08-15 | Merck Patent Gmbh | Verfahren zur Herstellung von Aminophenylessigsäure-Derivaten |
IT1193955B (it) * | 1980-07-22 | 1988-08-31 | Real Di Alberto Reiner S A S | Derivati ammidici dell'acido p-isobutilfenilpropionico, procedimento per la loro preparazione e relative composizioni farmaceutici |
IT1303249B1 (it) * | 1998-10-23 | 2000-11-06 | Dompe Spa | Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono. |
IT1303685B1 (it) * | 1998-10-30 | 2001-02-23 | Dompe Spa | Procedimento per la preparazione di acidi alfa-arilalcanoici |
IT1317826B1 (it) * | 2000-02-11 | 2003-07-15 | Dompe Spa | Ammidi, utili nell'inibizione della chemiotassi dei neutrofiliindotta da il-8. |
-
2000
- 2000-04-14 IT IT2000MI000836A patent/IT1318466B1/it active
-
2001
- 2001-04-11 AU AU2001246539A patent/AU2001246539B2/en not_active Ceased
- 2001-04-11 DK DK01919448T patent/DK1276732T3/da active
- 2001-04-11 CZ CZ20023773A patent/CZ303407B6/cs not_active IP Right Cessation
- 2001-04-11 AT AT01919448T patent/ATE374193T1/de active
- 2001-04-11 PT PT01919448T patent/PT1276732E/pt unknown
- 2001-04-11 AU AU4653901A patent/AU4653901A/xx active Pending
- 2001-04-11 DE DE60130644T patent/DE60130644T2/de not_active Expired - Lifetime
- 2001-04-11 WO PCT/EP2001/004137 patent/WO2001079189A2/en active IP Right Grant
- 2001-04-11 US US10/258,959 patent/US7217707B2/en not_active Expired - Lifetime
- 2001-04-11 RU RU2002130499/04A patent/RU2268263C2/ru not_active IP Right Cessation
- 2001-04-11 ES ES01919448T patent/ES2292574T3/es not_active Expired - Lifetime
- 2001-04-11 CA CA002420585A patent/CA2420585C/en not_active Expired - Fee Related
- 2001-04-11 EP EP01919448A patent/EP1276732B1/en not_active Expired - Lifetime
-
2002
- 2002-12-23 NO NO20026220A patent/NO325650B1/no not_active IP Right Cessation
-
2003
- 2003-04-04 HK HK03102428A patent/HK1051035A1/xx not_active IP Right Cessation
-
2007
- 2007-12-10 CY CY20071101566T patent/CY1107078T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CA2420585A1 (en) | 2001-10-25 |
CZ303407B6 (cs) | 2012-09-05 |
US20040186146A1 (en) | 2004-09-23 |
RU2268263C2 (ru) | 2006-01-20 |
EP1276732A1 (en) | 2003-01-22 |
ITMI20000836A0 (it) | 2000-04-14 |
ITMI20000836A1 (it) | 2001-10-14 |
IT1318466B1 (it) | 2003-08-25 |
DE60130644D1 (de) | 2007-11-08 |
HK1051035A1 (en) | 2003-07-18 |
CY1107078T1 (el) | 2012-10-24 |
NO325650B1 (no) | 2008-06-30 |
AU4653901A (en) | 2001-10-30 |
WO2001079189A3 (en) | 2003-10-09 |
DE60130644T2 (de) | 2008-08-14 |
EP1276732B1 (en) | 2007-09-26 |
NO20026220D0 (no) | 2002-12-23 |
NO20026220L (no) | 2002-12-23 |
US7217707B2 (en) | 2007-05-15 |
ATE374193T1 (de) | 2007-10-15 |
WO2001079189A2 (en) | 2001-10-25 |
CA2420585C (en) | 2009-11-03 |
ES2292574T3 (es) | 2008-03-16 |
AU2001246539B2 (en) | 2005-06-02 |
PT1276732E (pt) | 2007-12-06 |
CZ20023773A3 (cs) | 2003-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1255726T3 (da) | (R)-2-arylpropionamider anvendelige ved inhibiring af IL-8 induceret chemotaxi af neutrofiler | |
MXPA03006786A (es) | Omega-aminoalquilamidas de los acidos r-2-aril-propionicos como inhibidores de la quimiotaxis de las celulas mononucleadas y polimorfonucleadas. | |
MA27809A1 (fr) | Amides d'acide pyrrolopyridine-2-carboxylique inhibiteurs de glycogene-phosphorylase | |
MXPA04000278A (es) | Uso de antagonistas del receptor nk-1 con estructura piridinica para tratamiento de lesiones cerebrales, espinales o neuronales. | |
NO20045137L (no) | Diketohydrazinderivatforbindelser og legemidler inneholdende forbindelser som aktiv ingrediens | |
WO2001074791A1 (fr) | Derives de diazepane ou sels desdits composes | |
CY1107078T1 (el) | Αμιδια του r-2-(αμινοαρυλ)-προπιονικου οξεος για χρηση στην προληψη της ενεργοποιησης των λευκοκυτταρων | |
ATE412628T1 (de) | N- (1-dimethylaminocycloalkyl)methyl benzamid- derivate | |
RS52260B (en) | N- (2-hydroxyethyl) -N-methyl-4- (quinoline-8-yl (1- (thiazol-4-ylmethyl) piperidin-4-ylidene) methyl) benzamide, a process for its production as well as its use for treatment PAIN, TENSION AND DEPRESSION | |
HUP0300863A2 (hu) | N-(3,5-diklór-2-metoxi-fenil)-4-metoxi-3-(1-piperazinil)-benzolszulfonamid, eljárás elżállítására és a vegyületet tartalmazó gyógyszerkészítmény | |
BR0201569A (pt) | 4-(2-piridil) piperizinas possuindo uma atividade agonista do receptor 5ht7 | |
ATE521589T1 (de) | Amidine und derivate davon und pharmazeutische zusammensetzungen, die diese enthalten | |
EA200200187A1 (ru) | Производное 1,4,5,6-тетрагидропиримидина в качестве ингибитора витронектина | |
RU2003105827A (ru) | Средства против слабоумия, содержащие производные 2-арил-8-оксодигидропурина, в качестве активного ингредиента | |
RU2003114437A (ru) | Новые производные цианоарил (или цианогетероарил-карбонилпиперазинил-пиримидинов, их получения и применение в качестве лекарственного средства | |
ATE327221T1 (de) | Diamide, die tryptase und faktor-xa-aktivität hemmen | |
TH63263A (th) | N-[4(1H-อิมิดาซอล-1-อิล)-2-ฟลูออโรฟีนิล]-3-(ไตรฟลูออโรเมทธิล)-1H-ไพราโซล-5-คาร์บอกซาไมด์ ชนิดใหม่ในการเป็นการสารยับยั้งของแฟคเตอร์ Xa |